PreventiveMD GLP-1 prices
Cash-pay telehealth: US-licensed providers prescribe compounded semaglutide and tirzepatide from four 503A pharmacies at one all-in price per plan length at every dose, and Wegovy, Zepbound and Foundayo for a $49 monthly membership plus the medication (compounded is not FDA-approved). PreventiveMD has 2 sourced self-pay GLP-1 offers here. Advertised entry prices: Compounded semaglutide $119/mo; Compounded tirzepatide $139/mo. Plan terms, fees and the check date are listed with each quote.
Search by medication, provider or treatment goal. Examples follow.
2 offers · US self-pay · 2 maintenance quotes
Price conditions & source
Advertised price: 1-month supply that renews monthly and can be cancelled any time; $286 for a 3-month supply (~$95/mo), $536 for 6 months (~$89/mo) or $999 for 12 months (~$83/mo), longer plans paid upfront; the same price at every dose; provider review, medication, supplies, shipping and support included, no membership, consultation or cancellation fee
Maintenance terms: PreventiveMD prices by plan length, never by dose.
Weekly injection from one of four 503A pharmacies you choose at checkout (Empower, Midwest Compounders, Drug Crafters, Boudreaux's). The card is held, not charged, until a provider approves. Sales tax may be added. Compounded; not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price sourcePrice conditions & source
Advertised price: 1-month supply that renews monthly and can be cancelled any time; $334 for a 3-month supply (~$111/mo), $626 for 6 months (~$104/mo) or $1,168 for 12 months (~$97/mo), longer plans paid upfront; the same price at every dose; provider review, medication, supplies, shipping and support included, no membership, consultation or cancellation fee
Maintenance terms: PreventiveMD prices by plan length, never by dose.
Weekly injection from one of four 503A pharmacies you choose at checkout. The card is held, not charged, until a provider approves. Sales tax may be added. Compounded; not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source
Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.
Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.
The FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved, ending the exemption that let pharmacies mass-produce compounded copies, and the 503A/503B enforcement-discretion grace periods ended in 2025. The FDA is now actively enforcing (warning letters and takedowns, including a September 2026 warning letter to Empower Pharmacy, a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide), and in 2026 proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list (the public comment period, extended 30 days, closed July 30, 2026; a final decision is pending). Liraglutide is different: it is still on the FDA drug shortage list (brand Victoza and Saxenda in limited supply, generics available, as of September 2026). Compounded GLP-1s are not FDA-approved and are now generally limited to narrow, patient-specific 503A prescriptions, so broad low-cost availability has largely wound down. They also carry safety risks the branded products do not: FDA adverse-event reports, at least one sterility recall (ProRx, October 2025), and counterfeit product found in the US supply chain, so a low price is not a low-risk signal. Prices and availability below may lag these changes; confirm current terms with the provider.
PreventiveMD GLP-1 cost: common questions
How much does semaglutide cost through PreventiveMD?
Compounded semaglutide: $119/mo (1-month supply that renews monthly and can be cancelled any time; $286 for a 3-month supply (~$95/mo), $536 for 6 months (~$89/mo) or $999 for 12 months (~$83/mo), longer plans paid upfront; the same price at every dose; provider review, medication, supplies, shipping and support included, no membership, consultation or cancellation fee). Checked Oct 22, 2026; each quote links its source in the table. Compounded semaglutide is not an FDA-approved product.
How much does tirzepatide cost through PreventiveMD?
Compounded tirzepatide: $139/mo (1-month supply that renews monthly and can be cancelled any time; $334 for a 3-month supply (~$111/mo), $626 for 6 months (~$104/mo) or $1,168 for 12 months (~$97/mo), longer plans paid upfront; the same price at every dose; provider review, medication, supplies, shipping and support included, no membership, consultation or cancellation fee). Checked Oct 22, 2026; each quote links its source in the table. Compounded tirzepatide is not an FDA-approved product.
Does PreventiveMD offer FDA-approved GLP-1 medication or compounded versions?
The PreventiveMD offers tracked here are compounded: Compounded semaglutide; Compounded tirzepatide. Compounded GLP-1s are not FDA-approved products and are not reviewed by the FDA for safety, effectiveness, or quality.
When were PreventiveMD prices last checked?
Each quote carries its own check date and links the page it was read from: Oct 22, 2026 for the offers here. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.